Insider Buy Signals Confidence: Chemours Director’s Deferred Unit Purchase Boosts Investor Outlook
Chemours insider MATHER COURTNEY’s 1,305 deferred stock unit purchase signals confidence in the company’s sustainable‑chemical strategy, strong share gains, and future growth.
4 minutes to read